pentoxifylline has been researched along with Allergic Encephalomyelitis in 9 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of pentoxifylline (PTX) on experimental allergic encephalomyelitis (EAE) in mice, a known animal model of multiple sclerosis (MS), was investigated." | 7.69 | Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells. ( Fujimura, H; Okuda, Y; Sakoda, S; Yanagihara, T, 1996) |
| "Experimental allergic encephalomyelitis (EAE) is an inflammatory, CD4+ Th1-mediated autoimmune disease, which serves as a model for multiple sclerosis." | 5.30 | Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. ( Bright, JJ; Coon, M; Du, C; Klaus, SJ; Sriram, S, 1998) |
| "The pentoxifylline treated rats showed a significantly lower incidence of clinical signs as well as significantly lower histological inflammation." | 5.29 | Pentoxifylline inhibits experimental allergic encephalomyelitis. ( Chabannes, D; Fève, JR; Louboutin, JP; Muller, JY; Nataf, S, 1993) |
| "Experimental allergic encephalomyelitis (EAE) is an inflammatory, CD4+ Th1-mediated autoimmune disease, which serves as a model for multiple sclerosis." | 1.30 | Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline. ( Bright, JJ; Coon, M; Du, C; Klaus, SJ; Sriram, S, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corrêa, JO | 1 |
| Aarestrup, BJ | 1 |
| Aarestrup, FM | 1 |
| Pollak, Y | 1 |
| Ovadia, H | 1 |
| Orion, E | 1 |
| Yirmiya, R | 1 |
| Nataf, S | 1 |
| Louboutin, JP | 1 |
| Chabannes, D | 1 |
| Fève, JR | 1 |
| Muller, JY | 1 |
| Rott, O | 1 |
| Cash, E | 1 |
| Fleischer, B | 1 |
| Okuda, Y | 1 |
| Sakoda, S | 1 |
| Fujimura, H | 1 |
| Yanagihara, T | 1 |
| Clements, JM | 1 |
| Cossins, JA | 1 |
| Wells, GM | 1 |
| Corkill, DJ | 1 |
| Helfrich, K | 1 |
| Wood, LM | 1 |
| Pigott, R | 1 |
| Stabler, G | 1 |
| Ward, GA | 1 |
| Gearing, AJ | 1 |
| Miller, KM | 1 |
| Bright, JJ | 2 |
| Du, C | 2 |
| Coon, M | 1 |
| Sriram, S | 3 |
| Klaus, SJ | 2 |
| Cooper, JC | 1 |
1 review available for pentoxifylline and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Immunotherapy of inflammatory demyelinating diseases of the central nervous system.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; CD4-Positive T-Lymphocytes; Cerebrospinal F | 2001 |
8 other studies available for pentoxifylline and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE).
Topics: Animals; Brain; Encephalomyelitis, Autoimmune, Experimental; Female; Guinea Pigs; Immunosuppressive | 2010 |
The EAE-associated behavioral syndrome: II. Modulation by anti-inflammatory treatments.
Topics: Animals; Anti-Inflammatory Agents; Behavior, Animal; Dexamethasone; Encephalomyelitis, Autoimmune, E | 2003 |
Pentoxifylline inhibits experimental allergic encephalomyelitis.
Topics: Animals; Blood-Brain Barrier; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Macrop | 1993 |
Phosphodiesterase inhibitor pentoxifylline, a selective suppressor of T helper type 1- but not type 2-associated lymphokine production, prevents induction of experimental autoimmune encephalomyelitis in Lewis rats.
Topics: Animals; Bucladesine; Encephalomyelitis, Autoimmune, Experimental; Female; Immunosuppressive Agents; | 1993 |
Pentoxifylline delays the onset of experimental allergic encephalomyelitis in mice by modulating cytokine production in peripheral blood mononuclear cells.
Topics: Animals; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Female; Interleukin-1; Interleukin- | 1996 |
Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor.
Topics: Animals; Benzyl Compounds; Dexamethasone; Drug Combinations; Encephalomyelitis, Autoimmune, Experime | 1997 |
Prevention of experimental allergic encephalomyelitis via inhibition of IL-12 signaling and IL-12-mediated Th1 differentiation: an effect of the novel anti-inflammatory drug lisofylline.
Topics: Adoptive Transfer; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autoimmune Diseases; Cell Diffe | 1998 |
Amelioration of CR-EAE with lisofylline: effects on mRNA levels of IL-12 and IFN-gamma in the CNS.
Topics: Animals; Central Nervous System; Encephalomyelitis, Autoimmune, Experimental; Female; Gene Expressio | 2000 |